Trans Genic Inc.
Status: Publicly traded
Direct answer
Trans Genic Inc. is publicly traded on JPX under the ticker 2342.T.
Trans Genic Inc., a Japanese enterprise, specializes in the development, distribution, and licensing of genetically engineered animals and antibodies. Its operations are structured into two primary divisions: Drug Discovery Support Business and Investment Business. Within its Drug Discovery Support segment, the company offers a comprehensive array of services. These include the synthesis and analytical assessment of...
Can you invest in Trans Genic Inc.?
Yes. Trans Genic Inc. trades publicly on JPX as 2342.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Trans Genic Inc.
Detailed equity research is provided by MarketSnap.